120 related articles for article (PubMed ID: 25784290)
1. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
Allen-Rhoades W; Kurenbekova L; Satterfield L; Parikh N; Fuja D; Shuck RL; Rainusso N; Trucco M; Barkauskas DA; Jo E; Ahern C; Hilsenbeck S; Donehower LA; Yustein JT
Cancer Med; 2015 Jul; 4(7):977-88. PubMed ID: 25784290
[TBL] [Abstract][Full Text] [Related]
2. A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma.
Shao J; Zhang Y; Chang Z; Du S; Li W; Bai Y; Lu C; Xu T
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1758-1769. PubMed ID: 37814812
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.
Palmini G; Romagnoli C; Donati S; Zonefrati R; Galli G; Marini F; Iantomasi T; Aldinucci A; Leoncini G; Franchi A; Beltrami G; Campanacci DA; Capanna R; Brandi ML
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503899
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma.
Zhang J; Wang D; Xiong J; Chen L; Huang J
Oncol Lett; 2015 Oct; 10(4):2135-2141. PubMed ID: 26622808
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
Zhang N; Han Y; Cao H; Wang Q
J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
[TBL] [Abstract][Full Text] [Related]
7. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.
Lietz CE; Garbutt C; Barry WT; Deshpande V; Chen YL; Lozano-Calderon SA; Wang Y; Lawney B; Ebb D; Cote GM; Duan Z; Hornicek FJ; Choy E; Petur Nielsen G; Haibe-Kains B; Quackenbush J; Spentzos D
Sci Rep; 2020 Mar; 10(1):4409. PubMed ID: 32157112
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma.
Dailey DD; Hess AM; Bouma GJ; Duval DL
Front Vet Sci; 2021; 8():637622. PubMed ID: 33937369
[TBL] [Abstract][Full Text] [Related]
12. Impact of the genetic background on the composition of the chicken plasma MiRNome in response to a stress.
Ahanda ML; Zerjal T; Dhorne-Pollet S; Rau A; Cooksey A; Giuffra E
PLoS One; 2014; 9(12):e114598. PubMed ID: 25473826
[TBL] [Abstract][Full Text] [Related]
13. Future directions in the treatment of osteosarcoma.
Bishop MW; Janeway KA; Gorlick R
Curr Opin Pediatr; 2016 Feb; 28(1):26-33. PubMed ID: 26626558
[TBL] [Abstract][Full Text] [Related]
14. Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.
Makielski KM; Donnelly AJ; Khammanivong A; Scott MC; Ortiz AR; Galvan DC; Tomiyasu H; Amaya C; Ward KA; Montoya A; Garbe JR; Mills LJ; Cutter GR; Fenger JM; Kisseberth WC; O'Brien TD; Weigel BJ; Spector LG; Bryan BA; Subramanian S; Modiano JF
Lab Invest; 2021 Dec; 101(12):1585-1596. PubMed ID: 34489559
[TBL] [Abstract][Full Text] [Related]
15. Single-cell aggrephagy-related patterns facilitate tumor microenvironment intercellular communication, influencing osteosarcoma progression and prognosis.
Jiang Y; Ning Y; Cheng S; Huang Y; Deng M; Chen C
Apoptosis; 2024 Apr; 29(3-4):521-535. PubMed ID: 38066392
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers.
Sandau US; Wiedrick JT; McFarland TJ; Galasko DR; Fanning Z; Quinn JF; Saugstad JA
Sci Rep; 2024 Jan; 14(1):2148. PubMed ID: 38272952
[TBL] [Abstract][Full Text] [Related]
17. A novel alternative splicing-related prognostic signature for osteosarcoma.
Zhang J; Liang J; Chang X; Ge R
Asian J Surg; 2023 Dec; 46(12):5882-5884. PubMed ID: 37659943
[No Abstract] [Full Text] [Related]
18. Expression of the immune regulation antigen CD70 in osteosarcoma.
Pahl JH; Santos SJ; Kuijjer ML; Boerman GH; Sand LG; Szuhai K; Cleton-Jansen A; Egeler RM; Boveé JV; Schilham MW; Lankester AC
Cancer Cell Int; 2015; 15():31. PubMed ID: 25792975
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
Lee RJ; Arshi A; Schwartz HC; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients.
Laschi M; Bernardini G; Geminiani M; Ghezzi L; Amato L; Braconi D; Millucci L; Frediani B; Spreafico A; Franchi A; Campanacci D; Capanna R; Santucci A
J Cell Physiol; 2015 Nov; 230(11):2718-27. PubMed ID: 25809010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
